image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Bloomsbury Publishing - Publisher boosted by “romantasy” boom; FY24 eps forecast nearly doubled

April 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BMY
  • Price:
  • 550p
Over the month I met with Nigel Newton, founder and CEO of publisher Bloomsbury, and CFO Penny Scott-Bayfield. Readers may recall that Bloomsbury struck gold over 25 years ago by signing children’s author JK Rowling and her Harry Potter fantasy series to a seven-book deal after 12 other publishing houses had turned her down. But Bloomsbury’s bold decision to take the author was rewarded with a franchise that has since sold over 600 million copies worldwide, making it the best selling book series of all time. The children’s fantasy, about a boy who learns on his 11th birthday that he is the orphaned son of two powerful wizards and possesses unique magical powers of his own, opened up with Harry Potter and the Philosopher’s Stone, w ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author